文献速递脊柱外科小儿骨科

青少年胸椎特发性脊柱侧凸手术与非手术治疗的成本效用分析

Cost-Utility Analysis of Operative Versus Nonoperative Treatment of Thoracic Adolescent Idiopathic Scoliosis.
PubMed 文献 · Spine (Phila Pa 1976) · 2019-01-01

该成本效用分析基于决策模型,针对一名15岁骨骼成熟、55°右胸弯(Lenke 1型)的女孩,比较手术与非手术治疗的成本效用。手术在98.5%的模拟中被偏好,中位ICUR为20,600美元/QALY(95%CI 20,500-21,900),低于50,000美元/QALY的社会支付意愿阈值。

要点

  • 手术在98.5%的模拟中被偏好,中位ICUR为20,600美元/QALY。
  • 中位增量净货币效益为15,100美元(95%CI 14,800-15,700)。
  • 影响ICUR最大的因素为无并发症手术净成本、成年期手术和肺部并发症。

核心结论

  • 成本效用分析提示,对于Lenke 1型曲线的患者,手术治疗优于非手术治疗,且低于50,000美元/QALY的支付意愿阈值。

研究设计与样本

  • 成本效用分析,针对假设的15岁骨骼成熟、55°右胸弯(Lenke 1型)女孩建立决策分析模型比较手术与非手术治疗。

主要发现

  • 手术在98.5%的模拟中被偏好,中位ICUR为20,600美元/QALY(95%CI 20,500-21,900)。
  • 手术相关中位增量净货币效益为15,100美元(95%CI 14,800-15,700)。
  • 手术在不同支付意愿阈值下均产生净货币效益。
  • 对ICUR影响最大的因素为无并发症手术净成本、成年期手术和肺部并发症。

关键数值与推荐

  • 保守模型假设手术不直接带来QALY增益,且AIS患者健康效用与年龄匹配的美国人群均值相同。
  • 成本按每年3.22%通胀调整至2015年美元,成本和效益按3%贴现。
  • 中位ICUR 20,600美元/QALY(95%CI 20,500-21,900)低于50,000美元/QALY的支付意愿阈值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Cost-utility analysis OBJECTIVE.: To compare the cost utility of operative versus nonoperative treatment of adolescent idiopathic scoliosis (AIS) and identity factors that influence cost-utility estimates. SUMMARY OF BACKGROUND DATA: AIS affects 1% to 3% of children aged 10 to 16 years. When the major coronal curve reaches 50°, operative treatment may be considered. The cost utility of operative treatment of AIS is unknown. METHODS: A decision-analysis model comparing operative versus nonoperative treatment was developed for a hypothetical 15-year-old skeletally mature girl with a 55° right thoracic (Lenke 1) curve. The AIS literature was reviewed to estimate the probability, health utility, and quality-adjusted life years (QALYs) for each event. For the conservative model, we assumed that operative treatment did not result directly in any QALYs gained, and the health utility in AIS patients was the same as the age-matched US population mean. Costs were inflation-adjusted at 3.22% per year to 2015 US dollars. Costs and benefits were discounted at 3%. Probabilistic sensitivity analysis was performed using mixed first-order and second-order Monte Carlo simulations. Incremental cost utility ratio (ICUR) and incremental net monetary benefit were calculated. One-way sensitivity analyses were performed by varying cost, probability, and QALY estimates. RESULTS: Operative treatment was favored in 98.5% of simulations, with a median ICUR of $20,600/QALY (95% confidence interval, $20,500-$21,900) below the societal willingness-to-pay threshold (WTPT) of $50,000/QALY. The median incremental net monetary benefit associated with operative treatment was $15,100 (95% confidence interval, $14,800-$15,700). Operative treatment produced net monetary benefit across various WTPTs. Factors that most affected the ICUR were net costs associated with uncomplicated operative treatment, undergoing surgery during adulthood, and development of pulmonary complications. CONCLUSION: Cost-utility analysis suggests that operative treatment of AIS is favored over nonoperative treatment and falls below the $50,000/QALY WTPT for patients with Lenke 1 curves. LEVEL OF EVIDENCE: 2.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Jain A, Marks MC, Kelly MP, et al. Cost-Utility Analysis of Operative Versus Nonoperative Treatment of Thoracic Adolescent Idiopathic Scoliosis. Spine (Phila Pa 1976). 2019. PMID: 30475341. doi:10.1097/BRS.0000000000002936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。